1H-MRS technology combined with Lcmodel software were used to quantitative the concentration of metabolites of posterior cingulate gyrus (PCC) in Parkinson’s disease patients with(PDCI) and without cognitive impairment(PDN), and MMSE and MOCA tests were also performed. Compared with controls, the concentration of total creatine (tCr), N-acetylaspartate(NAA), myo-Inositol(mI), Glutathione (GSH), as well as glycerophosphocholine + phosphocholine (tCho) were found significantly decreased in PCC in PDCI group , but no changes were found in PDN. Additionally, correlations between concentration of tCr, GSH, tCho, NAA and MMSE (MoCA) scores can also be found . These results may indicate that the metabolites abnormalities in PCC might be used as a biomarker to track cognitive decline in Parkinson's disease in a clinical setting.
This abstract and the presentation materials are available to members only; a login is required.